| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryonic Stem Cells | 10 | 2014 | 59 | 2.130 |
Why?
|
| Induced Pluripotent Stem Cells | 6 | 2023 | 37 | 1.720 |
Why?
|
| Pluripotent Stem Cells | 8 | 2023 | 32 | 1.670 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 31 | 1.010 |
Why?
|
| Fertilization | 10 | 2019 | 38 | 0.980 |
Why?
|
| Cell Culture Techniques | 6 | 2018 | 142 | 0.950 |
Why?
|
| Models, Animal | 3 | 2016 | 134 | 0.720 |
Why?
|
| Papio anubis | 1 | 2018 | 5 | 0.630 |
Why?
|
| Centrosome | 6 | 1999 | 28 | 0.610 |
Why?
|
| Stem Cells | 4 | 2016 | 141 | 0.600 |
Why?
|
| Animals | 49 | 2023 | 15081 | 0.570 |
Why?
|
| Cell Differentiation | 10 | 2023 | 587 | 0.550 |
Why?
|
| Spermatozoa | 9 | 2019 | 200 | 0.500 |
Why?
|
| Parkinson Disease | 1 | 2016 | 178 | 0.490 |
Why?
|
| Primates | 3 | 2019 | 36 | 0.490 |
Why?
|
| Microtubules | 12 | 2019 | 120 | 0.490 |
Why?
|
| Macaca mulatta | 7 | 2019 | 128 | 0.480 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 32 | 0.470 |
Why?
|
| Oocytes | 13 | 2019 | 146 | 0.450 |
Why?
|
| Zygote | 8 | 2019 | 39 | 0.450 |
Why?
|
| Fertilization in Vitro | 10 | 2019 | 54 | 0.450 |
Why?
|
| Mast Cells | 6 | 2016 | 81 | 0.420 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2018 | 286 | 0.410 |
Why?
|
| G2 Phase | 2 | 2009 | 29 | 0.390 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2004 | 132 | 0.390 |
Why?
|
| Cells, Cultured | 9 | 2018 | 1518 | 0.390 |
Why?
|
| Nuclear Transfer Techniques | 4 | 2004 | 15 | 0.370 |
Why?
|
| Mitochondria | 4 | 2009 | 487 | 0.370 |
Why?
|
| DNA-Binding Proteins | 4 | 2009 | 539 | 0.370 |
Why?
|
| Francisella tularensis | 3 | 2016 | 115 | 0.350 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 13 | 0.350 |
Why?
|
| G1 Phase | 1 | 2009 | 33 | 0.350 |
Why?
|
| Cloning, Organism | 3 | 2004 | 22 | 0.340 |
Why?
|
| Enzyme Inhibitors | 5 | 2010 | 433 | 0.340 |
Why?
|
| Mice | 19 | 2023 | 5913 | 0.330 |
Why?
|
| Antineoplastic Agents | 9 | 2001 | 803 | 0.330 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 229 | 0.330 |
Why?
|
| Tularemia | 4 | 2018 | 114 | 0.320 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 893 | 0.320 |
Why?
|
| Cytoskeleton | 5 | 2004 | 110 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 448 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 194 | 0.300 |
Why?
|
| Pedigree | 1 | 2007 | 79 | 0.300 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 62 | 0.280 |
Why?
|
| Gene Expression | 4 | 2014 | 674 | 0.280 |
Why?
|
| Papio | 3 | 2016 | 22 | 0.280 |
Why?
|
| Drug Design | 4 | 2004 | 162 | 0.280 |
Why?
|
| Organometallic Compounds | 3 | 2001 | 73 | 0.280 |
Why?
|
| Blastocyst | 3 | 2008 | 48 | 0.270 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 45 | 0.250 |
Why?
|
| Microscopy, Confocal | 9 | 2016 | 218 | 0.240 |
Why?
|
| Cell Cycle | 5 | 2011 | 326 | 0.240 |
Why?
|
| Mammals | 2 | 1995 | 105 | 0.240 |
Why?
|
| Enzyme Precursors | 1 | 2004 | 14 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 626 | 0.230 |
Why?
|
| Macrophages | 2 | 2018 | 439 | 0.230 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2014 | 19 | 0.230 |
Why?
|
| Tubulin | 5 | 2001 | 88 | 0.220 |
Why?
|
| Humans | 40 | 2023 | 37093 | 0.220 |
Why?
|
| Karyotyping | 3 | 2013 | 47 | 0.210 |
Why?
|
| Cell Nucleus | 6 | 2019 | 366 | 0.210 |
Why?
|
| Infertility, Male | 3 | 1997 | 45 | 0.210 |
Why?
|
| Base Sequence | 6 | 2013 | 997 | 0.200 |
Why?
|
| Parthenogenesis | 3 | 2019 | 9 | 0.200 |
Why?
|
| Vanadium Compounds | 1 | 2001 | 1 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2018 | 1908 | 0.190 |
Why?
|
| Bone Regeneration | 1 | 2020 | 4 | 0.190 |
Why?
|
| Quinazolines | 4 | 2002 | 33 | 0.190 |
Why?
|
| Male | 25 | 2019 | 20025 | 0.180 |
Why?
|
| Furans | 4 | 2001 | 38 | 0.180 |
Why?
|
| Cell Line | 6 | 2009 | 1354 | 0.180 |
Why?
|
| DNA Primers | 2 | 2013 | 286 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2001 | 39 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 67 | 0.180 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2019 | 68 | 0.170 |
Why?
|
| Cattle | 8 | 2004 | 477 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2010 | 272 | 0.160 |
Why?
|
| Embryo, Mammalian | 4 | 2011 | 153 | 0.160 |
Why?
|
| Phagosomes | 1 | 2018 | 30 | 0.160 |
Why?
|
| Osteogenesis | 2 | 2020 | 35 | 0.150 |
Why?
|
| Receptors, IgE | 2 | 2016 | 23 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2018 | 43 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 2 | 2009 | 28 | 0.150 |
Why?
|
| Female | 25 | 2019 | 20969 | 0.150 |
Why?
|
| Pyrans | 3 | 2001 | 10 | 0.150 |
Why?
|
| Spiro Compounds | 3 | 2001 | 12 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 11 | 2001 | 502 | 0.150 |
Why?
|
| Fathers | 1 | 1997 | 33 | 0.140 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2016 | 10 | 0.140 |
Why?
|
| Caspase 1 | 1 | 2016 | 15 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 64 | 0.140 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 72 | 0.140 |
Why?
|
| Protein Isoforms | 3 | 2014 | 130 | 0.130 |
Why?
|
| Transcription Factors | 4 | 2005 | 681 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 223 | 0.130 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 125 | 0.130 |
Why?
|
| Rodentia | 1 | 1995 | 43 | 0.120 |
Why?
|
| Dopamine | 1 | 2016 | 245 | 0.120 |
Why?
|
| Fertility | 1 | 1995 | 59 | 0.120 |
Why?
|
| Action Potentials | 1 | 2016 | 231 | 0.120 |
Why?
|
| Reproduction | 1 | 1995 | 71 | 0.120 |
Why?
|
| Sperm Head | 1 | 1994 | 10 | 0.120 |
Why?
|
| Apoptosis | 5 | 2014 | 1398 | 0.110 |
Why?
|
| Genetic Variation | 1 | 1996 | 387 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 409 | 0.110 |
Why?
|
| Cell Division | 3 | 2006 | 307 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2006 | 166 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2014 | 1207 | 0.110 |
Why?
|
| Embryo Transfer | 4 | 2011 | 33 | 0.110 |
Why?
|
| Osteoblasts | 1 | 2012 | 35 | 0.110 |
Why?
|
| Electric Stimulation | 1 | 2012 | 184 | 0.110 |
Why?
|
| Microinjections | 3 | 2004 | 57 | 0.110 |
Why?
|
| Mice, SCID | 3 | 2009 | 150 | 0.100 |
Why?
|
| Tissue Engineering | 1 | 2012 | 60 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1198 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 27 | 0.100 |
Why?
|
| Meiosis | 3 | 2004 | 62 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 623 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 132 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2001 | 14 | 0.100 |
Why?
|
| Chimera | 1 | 2011 | 15 | 0.100 |
Why?
|
| Haplorhini | 1 | 2011 | 22 | 0.100 |
Why?
|
| Teratoma | 2 | 2009 | 9 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 208 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 295 | 0.090 |
Why?
|
| Genomic Instability | 1 | 2011 | 38 | 0.090 |
Why?
|
| Farnesyltranstransferase | 1 | 2010 | 4 | 0.090 |
Why?
|
| Progeria | 1 | 2010 | 9 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 187 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 35 | 0.090 |
Why?
|
| Phenotype | 2 | 2007 | 689 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 109 | 0.090 |
Why?
|
| Models, Biological | 2 | 2009 | 677 | 0.090 |
Why?
|
| Insulin | 2 | 2009 | 236 | 0.090 |
Why?
|
| Antimycin A | 1 | 2009 | 5 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 13 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2009 | 36 | 0.090 |
Why?
|
| Gamma Rays | 1 | 2009 | 26 | 0.090 |
Why?
|
| Sperm-Ovum Interactions | 4 | 1996 | 13 | 0.090 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 35 | 0.090 |
Why?
|
| DNA Repair | 1 | 2010 | 188 | 0.080 |
Why?
|
| Immunity, Innate | 3 | 2018 | 149 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2008 | 35 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2009 | 928 | 0.080 |
Why?
|
| DNA, Mitochondrial | 2 | 2006 | 175 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 5 | 2006 | 252 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 90 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2009 | 859 | 0.070 |
Why?
|
| Cell Separation | 1 | 2007 | 93 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 461 | 0.070 |
Why?
|
| C-Peptide | 1 | 2005 | 7 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 1502 | 0.070 |
Why?
|
| Pregnancy | 3 | 2011 | 1549 | 0.070 |
Why?
|
| Flow Cytometry | 3 | 2002 | 399 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1609 | 0.060 |
Why?
|
| Interleukin-4 | 2 | 2018 | 72 | 0.060 |
Why?
|
| Peritonitis | 2 | 2002 | 9 | 0.060 |
Why?
|
| Chromatin | 2 | 1996 | 169 | 0.060 |
Why?
|
| Macaca | 1 | 2004 | 38 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 69 | 0.060 |
Why?
|
| Escherichia coli Infections | 2 | 2002 | 41 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2004 | 76 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 2005 | 66 | 0.060 |
Why?
|
| Cytoplasm | 3 | 2004 | 143 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2001 | 83 | 0.060 |
Why?
|
| Genome | 1 | 2004 | 125 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1999 | 807 | 0.060 |
Why?
|
| Protein Transport | 2 | 2016 | 302 | 0.060 |
Why?
|
| Callithrix | 1 | 2023 | 9 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2003 | 23 | 0.060 |
Why?
|
| Electroporation | 1 | 2003 | 18 | 0.060 |
Why?
|
| Zebrafish | 2 | 2001 | 128 | 0.050 |
Why?
|
| DNA | 4 | 2000 | 574 | 0.050 |
Why?
|
| Thrombopoietin | 1 | 2002 | 4 | 0.050 |
Why?
|
| P-Selectin | 1 | 2002 | 7 | 0.050 |
Why?
|
| Germ Cells | 1 | 2023 | 73 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 661 | 0.050 |
Why?
|
| Transfection | 2 | 2018 | 523 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 72 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 107 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2002 | 77 | 0.050 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 2 | 0.050 |
Why?
|
| Vanadium | 1 | 2001 | 6 | 0.050 |
Why?
|
| Leukotriene C4 | 1 | 2000 | 6 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 1999 | 163 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2001 | 59 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 12 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 59 | 0.050 |
Why?
|
| Calcium Phosphates | 1 | 2020 | 13 | 0.050 |
Why?
|
| Calcification, Physiologic | 1 | 2020 | 13 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2000 | 31 | 0.050 |
Why?
|
| Neutrophils | 1 | 2001 | 131 | 0.050 |
Why?
|
| Materials Testing | 1 | 2020 | 69 | 0.050 |
Why?
|
| Fatty Alcohols | 1 | 2000 | 7 | 0.050 |
Why?
|
| Femur | 1 | 2020 | 36 | 0.050 |
Why?
|
| Vanadates | 1 | 2000 | 8 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2001 | 55 | 0.050 |
Why?
|
| Disulfides | 2 | 1999 | 77 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2020 | 129 | 0.050 |
Why?
|
| Sperm Tail | 2 | 1996 | 3 | 0.050 |
Why?
|
| Mitosis | 1 | 2001 | 99 | 0.050 |
Why?
|
| Extrachromosomal Inheritance | 1 | 1999 | 2 | 0.040 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1999 | 8 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 64 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 1999 | 18 | 0.040 |
Why?
|
| Collagen | 1 | 2020 | 172 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 1999 | 85 | 0.040 |
Why?
|
| Aniline Compounds | 1 | 1998 | 23 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 1999 | 55 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 1999 | 41 | 0.040 |
Why?
|
| Nitriles | 1 | 1998 | 69 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 269 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 15 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2018 | 16 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 36 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2005 | 1568 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 185 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 54 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 1997 | 6 | 0.040 |
Why?
|
| Dithiothreitol | 1 | 1997 | 18 | 0.040 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 7 | 0.040 |
Why?
|
| Micromanipulation | 1 | 1996 | 12 | 0.040 |
Why?
|
| Morula | 1 | 1996 | 2 | 0.040 |
Why?
|
| Estrus | 1 | 1996 | 14 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 578 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2016 | 101 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Immunity | 1 | 2016 | 53 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 3483 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 89 | 0.030 |
Why?
|
| Cell Communication | 1 | 2016 | 97 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1618 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 199 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 316 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 3 | 1999 | 8 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 250 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2012 | 933 | 0.030 |
Why?
|
| Marsupialia | 1 | 1994 | 4 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2005 | 1180 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1996 | 550 | 0.030 |
Why?
|
| Paclitaxel | 2 | 2004 | 50 | 0.030 |
Why?
|
| Blastomeres | 2 | 2009 | 9 | 0.030 |
Why?
|
| Actins | 1 | 1995 | 148 | 0.030 |
Why?
|
| Neoplasms | 2 | 2001 | 1103 | 0.030 |
Why?
|
| Chromosomes | 2 | 2004 | 37 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2004 | 110 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 8 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2012 | 37 | 0.030 |
Why?
|
| Cell Survival | 3 | 2001 | 864 | 0.030 |
Why?
|
| Child | 4 | 2001 | 3131 | 0.030 |
Why?
|
| Benzimidazoles | 2 | 2006 | 36 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2000 | 808 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 62 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 307 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2001 | 6 | 0.020 |
Why?
|
| Janus Kinase 3 | 2 | 2001 | 35 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 40 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 181 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 267 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 32 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 474 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 74 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 22 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1999 | 77 | 0.020 |
Why?
|
| Zinc Fingers | 2 | 1999 | 26 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 10 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2009 | 11 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2000 | 113 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 22 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 136 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 207 | 0.020 |
Why?
|
| Telomerase | 1 | 2009 | 44 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2000 | 389 | 0.020 |
Why?
|
| Calcium | 2 | 2002 | 480 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 176 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 1039 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 209 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2006 | 14 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 20 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 80 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 75 | 0.020 |
Why?
|
| Infant | 2 | 1999 | 1046 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 223 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2004 | 2 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2004 | 8 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1999 | 1418 | 0.020 |
Why?
|
| Molecular Motor Proteins | 1 | 2004 | 9 | 0.020 |
Why?
|
| Genome, Human | 1 | 2006 | 135 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 59 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2008 | 325 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 73 | 0.020 |
Why?
|
| Mutation | 2 | 1999 | 1095 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 241 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 190 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 20 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2002 | 1 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 11 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2002 | 69 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2002 | 112 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2001 | 22 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 2001 | 5 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2001 | 13 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 16 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 14 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 37 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2001 | 22 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 2001 | 2 | 0.010 |
Why?
|
| Pentanones | 1 | 2001 | 4 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 45 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 42 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 74 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2001 | 45 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 113 | 0.010 |
Why?
|
| Calcimycin | 1 | 2000 | 12 | 0.010 |
Why?
|
| Eosinophils | 1 | 2000 | 20 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2001 | 121 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2000 | 10 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2000 | 35 | 0.010 |
Why?
|
| Drug Stability | 1 | 2001 | 116 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2001 | 73 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 515 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2001 | 265 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2000 | 32 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 152 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 133 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 90 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 409 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1999 | 16 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 13 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 651 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1999 | 73 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 111 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1999 | 93 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2001 | 492 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 356 | 0.010 |
Why?
|
| Fatty Acid Desaturases | 1 | 1999 | 4 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 1999 | 8 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2001 | 222 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 453 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1998 | 21 | 0.010 |
Why?
|
| Isoxazoles | 1 | 1998 | 11 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 116 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1999 | 90 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 87 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1999 | 66 | 0.010 |
Why?
|
| Prognosis | 1 | 2001 | 739 | 0.010 |
Why?
|
| Plant Proteins | 1 | 1999 | 93 | 0.010 |
Why?
|
| Sea Urchins | 1 | 1997 | 9 | 0.010 |
Why?
|
| Amphibians | 1 | 1997 | 10 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1997 | 22 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 562 | 0.010 |
Why?
|
| Acrosome | 1 | 1996 | 2 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1996 | 4 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 1378 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1997 | 142 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 213 | 0.010 |
Why?
|
| Insemination, Artificial | 1 | 1996 | 9 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1999 | 305 | 0.010 |
Why?
|
| Injections | 1 | 1996 | 35 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 421 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 357 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 90 | 0.010 |
Why?
|
| Parents | 1 | 1999 | 329 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1997 | 431 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1999 | 935 | 0.010 |
Why?
|
| Centrioles | 1 | 1994 | 2 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1996 | 381 | 0.010 |
Why?
|
| Adult | 2 | 1999 | 11712 | 0.010 |
Why?
|
| Risk Factors | 1 | 2001 | 3562 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 5363 | 0.010 |
Why?
|